InsidersTradesSigma
Browse the full record of transactions filed by Thackaberry Evan, SVP, Responsable du Développement Précoce. Director active across 1 company, notably Vigil Neuroscience, Inc.. In total, 1 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €6k. History available since 5 May 2022. The latest transaction was filed on 5 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Evan Thackaberry is the Senior Vice President and Head of Early Development at Vigil Neuroscience, Inc. He oversees research and development initiatives, focusing on innovation in the field of neuroscience. Thackaberry brings valuable expertise to guide the company's projects towards advanced therapeutic solutions.